Lasers in Medical Science

, Volume 22, Issue 2, pp 83–91 | Cite as

Anti-microbial photodynamic therapy: useful in the future?

Original article


Previous chapters in this volume have focused on fundamental principles and clinical applications of PDT. This chapter will attempt to outline emerging areas of research to identify some new applications that may become useful in the future in clinical practise. The worldwide rise in antibiotic resistance has driven research to the development of novel anti-microbial strategies. Cutaneous diseases caused by MRSA are ideally suited to treatment by anti-microbial photodynamic therapy for eradicating localized infections and for modulating wound healing due to the ability to deliver photosensitizer and light with topical application. The use of photosensitizer and light as an anti-microbial agent against periodontal microbial biofilms should also represent an attractive method of eliminating oral bacteria. Suitable light sources, laser light and non-coherent light will be briefly covered. This chapter will focus on some aspects of anti-microbial photodynamic therapy that appear to be promising for dermatological indications and inactivation of pathogenic bacteria within the oral cavity.


Anti-microbial photodynamic therapy Oral bacteria MRSA Photosensitizer Porphyrin-photosensitization 


  1. 1.
    Anwar H, Dasgupta MK, Costerton JW (1990) Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother 34:2043–2046PubMedGoogle Scholar
  2. 2.
    Bach G, Neckel C, Mall C, Krekeler G (2000) Conventional versus laser-assisted therapy of periimplantitis: a five-year comparative study. Implant Dent 9:247–251PubMedCrossRefGoogle Scholar
  3. 3.
    Baeumler W (2001) Light sources for photodynamic therapy and fluorescence diagnosis in dermatology. Comprehensive series in photoscience, 1st edn, vol 2. Elsevier, pp 83–98Google Scholar
  4. 4.
    Bertoloni G, Rossi F, Valduga G, Jori G, Ali H, van Lier JE (1992) Photosensitizing activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios 71:33–46PubMedGoogle Scholar
  5. 5.
    Bliss JM, Bigelow CE, Foster TH, Haidaris CG (2004) Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob Agents Chemother 48:2000–2006PubMedCrossRefGoogle Scholar
  6. 6.
    Boehncke WH, Elshorst-Schmidt T, Kaufmann R (2000) Systemic photodynamic therapy is a safe and effective treatment for psoriasis. Arch Dermatol 136:271–272PubMedCrossRefGoogle Scholar
  7. 7.
    Boehncke WH, Sterry W, Kaufmann R (1994) Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343:801PubMedCrossRefGoogle Scholar
  8. 8.
    Bytzer P, O’Morain C (2005) Treatment of Helicobacter pylori. Helicobacter 10(Suppl 1):40–46PubMedCrossRefGoogle Scholar
  9. 9.
    Calzavara-Pinton PG, Venturini M, Sala R (2005) A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B 78:1–6PubMedCrossRefGoogle Scholar
  10. 10.
    Carbon C (1999) Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother 44(Suppl A):31–36PubMedCrossRefGoogle Scholar
  11. 11.
    Chan Y, Lai CH (2003) Bactericidal effects of different laser wavelengths on periodontopathic germs in photodynamic therapy. Lasers Med Sci 18:51–55PubMedCrossRefGoogle Scholar
  12. 12.
    Collins P, Robinson DJ, Stringer MR, Stables GI, Sheehan-Dare RA (1997) The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 137:743–749PubMedCrossRefGoogle Scholar
  13. 13.
    Colsky AS, Kirsner RS, Kerdel FA (1998) Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. Arch Dermatol 134:1006–1009PubMedCrossRefGoogle Scholar
  14. 14.
    Colsky AS, Kirsner RS, Kerdel FA (1998) Microbiologic evaluation of cutaneous wounds in hospitalized dermatology patients. Ostomy Wound Manage 44:40–42, 44, 46PubMedGoogle Scholar
  15. 15.
    Cookson BD, Farrelly H, Stapleton P, Garvey RP, Price MR (1991) Transferable resistance to triclosan in MRSA. Lancet 337:1548–1549PubMedCrossRefGoogle Scholar
  16. 16.
    Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322PubMedCrossRefGoogle Scholar
  17. 17.
    Cove JH, Holland KT, Cunliffe WJ (1980) An analysis of sebum excretion rate, bacterial population and the production rate of free fatty acids on human skin. Br J Dermatol 103:383–386PubMedCrossRefGoogle Scholar
  18. 18.
    Dierickx CC, Goldenhersh M, Dwyer P, Stratigos A, Mihm M, Anderson RR (1999) Photodynamic therapy for nevus sebaceus with topical delta-aminolevulinic acid. Arch Dermatol 135:637–640PubMedCrossRefGoogle Scholar
  19. 19.
    Divaris DX, Kennedy JC, Pottier RH (1990) Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 136:891–897PubMedGoogle Scholar
  20. 20.
    Dobson J, Wilson M (1992) Sensitization of oral bacteria in biofilms to killing by light from a low-power laser. Arch Oral Biol 37:883–887PubMedCrossRefGoogle Scholar
  21. 21.
    Dortbudak O, Haas R, Bernhart T, Mailath-Pokorny G (2001) Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis. Clin Oral Implants Res 12:104–108PubMedCrossRefGoogle Scholar
  22. 22.
    Eady EA, Cove JH, Holland KT, Cunliffe WJ (1989) Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 121:51–57PubMedCrossRefGoogle Scholar
  23. 23.
    Estey EP, Brown K, Diwu Z, Liu J, Lown JW, Miller GG, Moore RB, Tulip J, McPhee MS (1996) Hypocrellins as photosensitizers for photodynamic therapy: a screening evaluation and pharmacokinetic study. Cancer Chemother Pharmacol 37:343–350PubMedCrossRefGoogle Scholar
  24. 24.
    Ferro S, Ricchelli F, Mancini G, Tognon G, Jori G (2006) Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) by liposome-delivered photosensitising agents. J Photochem Photobiol B 83:98–104PubMedCrossRefGoogle Scholar
  25. 25.
    Filius PM, Gyssens IC (2002) Impact of increasing antimicrobial resistance on wound management. Am J Clin Dermatol 3:1–7PubMedCrossRefGoogle Scholar
  26. 26.
    Fridkin SK (2001) Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 32:108–115PubMedCrossRefGoogle Scholar
  27. 27.
    Fritsch C, Lehmann P, Stahl W, Schulte KW, Blohm E, Lang K, Sies H, Ruzicka T (1999) Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid. Br J Cancer 79:1603–1608PubMedCrossRefGoogle Scholar
  28. 28.
    Fry L (1988) Psoriasis. Br J Dermatol 119:445–461PubMedCrossRefGoogle Scholar
  29. 29.
    Ganz RA, Viveiros J, Ahmad A, Ahmadi A, Khalil A, Tolkoff MJ, Nishioka NS, Hamblin MR (2005) Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 36:260–265PubMedCrossRefGoogle Scholar
  30. 30.
    Gollnick SO, Liu X, Owczarczak B, Musser DA, Henderson BW (1997) Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 57:3904–3909PubMedGoogle Scholar
  31. 31.
    Guiotto A, Chilin A, Manzini P, Dall’Acqua F, Bordin F, Rodighiero P (1995) Synthesis and antiproliferative activity of furocoumarin isosters. Farmaco 50:479–488PubMedGoogle Scholar
  32. 32.
    Hamblin MR, O’Donnell DA, Murthy N, Contag CH, Hasan T (2002) Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol 75:51–57PubMedCrossRefGoogle Scholar
  33. 33.
    Hamblin MR, Viveiros J, Yang C, Ahmadi A, Ganz RA, Tolkoff MJ (2005) Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother 49:2822–2827PubMedCrossRefGoogle Scholar
  34. 34.
    Harkaway KS, McGinley KJ, Foglia AN, Lee WL, Fried F, Shalita AR, Leyden JJ (1992) Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol 126:586–590PubMedCrossRefGoogle Scholar
  35. 35.
    Henderson CA, Highet AS (1988) Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections. Br J Dermatol 118:559–561PubMedCrossRefGoogle Scholar
  36. 36.
    Hoiby N, Jarlov JO, Kemp M, Tvede M, Bangsborg JM, Kjerulf A, Pers C, Hansen H (1997) Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 349:167–169PubMedCrossRefGoogle Scholar
  37. 37.
    Itoh Y, Ninomiya Y, Tajima S, Ishibashi A (2001) Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 144:575–579PubMedCrossRefGoogle Scholar
  38. 38.
    Johnson EM, Warnock DW, Luker J, Porter SR, Scully C (1995) Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 35:103–114PubMedCrossRefGoogle Scholar
  39. 39.
    Kaye ET (2000) Topical antibacterial agents: role in prophylaxis and treatment of bacterial infections. Curr Clin Top Infect Dis 20:43–62PubMedGoogle Scholar
  40. 40.
    Kjeldstad B, Johnsson A (1986) An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitization. Photochem Photobiol 43:67–70PubMedGoogle Scholar
  41. 41.
    Kjeldstad B, Johnsson A, Sandberg S (1984) Influence of pH on porphyrin production in Propionibacterium acnes. Arch Dermatol Res 276:396–400PubMedCrossRefGoogle Scholar
  42. 42.
    Kojima T, Shimada K, Iwasaki H, Ito K (2005) Inhibitory effects of a super pulsed carbon dioxide laser at low energy density on periodontopathic bacteria and lipopolysaccharide in vitro. J Periodontal Res 40:469–473PubMedCrossRefGoogle Scholar
  43. 43.
    Kreitner M, Wagner KH, Alth G, Ebermann R, Foissy H, Elmadfa I (2003) Finding optimal photosensitisers for the decontamination of foods by the photodynamic effect. Forum Nutr 56:367–369PubMedGoogle Scholar
  44. 44.
    Kresken M, Hafner D, Studiengruppe UD (2000) Resistenzentwicklung bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa. Chemotherapie J 9:1–36Google Scholar
  45. 45.
    Lee WL, Shalita AR, Suntharalingam K, Fikrig SM (1982) Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect Immun 35:71–78PubMedGoogle Scholar
  46. 46.
    Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, Hanifin JM, Sampson HA (1993) Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 92:1374–1380PubMedCrossRefGoogle Scholar
  47. 47.
    Maisch T, Bosl C, Szeimies RM, Lehn N, Abels C (2005) Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother 49:1542–1552PubMedCrossRefGoogle Scholar
  48. 48.
    Maisch T, Szeimies RM, Jori G, Abels C (2004) Antibacterial photodynamic therapy in dermatology. Photochem Photobiol Sci 3:907–917PubMedCrossRefGoogle Scholar
  49. 49.
    Malik Z, Faraggi A, Savion N (1992) Ultrastructural damage in photosensitized endothelial cells: dependence on hematoporphyrin delivery pathways. J Photochem Photobiol B 14:359–368PubMedCrossRefGoogle Scholar
  50. 50.
    Marples RR, Heaton CL, Kligman AM (1973) Staphylococcus aureus in psoriasis. Arch Dermatol 107:568–570PubMedCrossRefGoogle Scholar
  51. 51.
    Meisel P, Kocher T (2005) Photodynamic therapy for periodontal diseases: state of the art. J Photochem Photobiol B 79:159–170PubMedCrossRefGoogle Scholar
  52. 52.
    Menezes S, Capella MA, Caldas LR (1990) Photodynamic action of methylene blue: repair and mutation in Escherichia coli. J Photochem Photobiol B 5:505–517PubMedCrossRefGoogle Scholar
  53. 53.
    Merchat M, Bertolini G, Giacomini P, Villanueva A, Jori G (1996) Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria. J Photochem Photobiol B 32:153–157PubMedCrossRefGoogle Scholar
  54. 54.
    Merchat M, Spikes JD, Bertoloni G, Jori G (1996) Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins. J Photochem Photobiol B 35:149–157PubMedCrossRefGoogle Scholar
  55. 55.
    Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown SB (2000) Mechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli. Antimicrob Agents Chemother 44:522–527PubMedCrossRefGoogle Scholar
  56. 56.
    Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown ST (1996) Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J Photochem Photobiol B 32:159–164PubMedCrossRefGoogle Scholar
  57. 57.
    Monfrecola G, Procaccini EM, Bevilacqua M, Manco A, Calabro G, Santoianni P (2004) In vitro effect of 5-aminolaevulinic acid plus visible light on Candida albicans. Photochem Photobiol Sci 3:419–422PubMedCrossRefGoogle Scholar
  58. 58.
    Morison WL (1998) Variations of PUVA: practical and effective? Arch Dermatol 134:1286–1288PubMedCrossRefGoogle Scholar
  59. 59.
    Morison WL, Baughman RD, Day RM, Forbes PD, Hoenigsmann H, Krueger GG, Lebwohl M, Lew R, Naldi L, Parrish JA, Piepkorn M, Stern RS, Weinstein GD, Whitmore SE (1998) Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol 134:595–598PubMedCrossRefGoogle Scholar
  60. 60.
    Nichols RL (1999) Optimal treatment of complicated skin and skin structure infections. J Antimicrob Chemother 44(Suppl A):19–23PubMedCrossRefGoogle Scholar
  61. 61.
    Nishijima S, Namura S, Mitsuya K, Asada Y (1993) The incidence of isolation of methicillin-resistant Staphylococcus aureus (MRSA) strains from skin infections during the past three years (1989–1991). J Dermatol 20:193–197PubMedGoogle Scholar
  62. 62.
    Nitzan Y, Gutterman M, Malik Z, Ehrenberg B (1992) Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol 55:89–96PubMedGoogle Scholar
  63. 63.
    Norris DA, Travers JB, Leung DY (1997) Lymphocyte activation in the pathogenesis of psoriasis. J Invest Dermatol 109:1–4PubMedCrossRefGoogle Scholar
  64. 64.
    Raab O (1900) Ueber die Wirkung fluorizierender Stoffe auf Infusorien. Z Biol 39:524–546Google Scholar
  65. 65.
    Rietschel RL (1994) Dermatologic manifestations of antimicrobial adverse reactions with special emphasis on topical exposure. Infect Dis Clin North Am 8:607–615PubMedGoogle Scholar
  66. 66.
    Robinson DJ, Collins P, Stringer MR, Vernon DI, Stables GI, Brown SB, Sheehan-Dare RA (1999) Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 79:451–455PubMedCrossRefGoogle Scholar
  67. 67.
    Rosenberg EW, Belew PW (1982) Microbial factors in psoriasis. Arch Dermatol 118:143–144PubMedCrossRefGoogle Scholar
  68. 68.
    Sakellari D, Goodson JM, Kolokotronis A, Konstantinidis A (2000) Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 27:53–60PubMedCrossRefGoogle Scholar
  69. 69.
    Sarkar S, Wilson M (1993) Lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis. J Periodontal Res 28:204–210PubMedCrossRefGoogle Scholar
  70. 70.
    Schafer M, Schmitz C, Horneck G (1998) High sensitivity of Deinococcus radiodurans to photodynamically-produced singlet oxygen. Int J Radiat Biol 74:249–253PubMedCrossRefGoogle Scholar
  71. 71.
    Seal GJ, Ng YL, Spratt D, Bhatti M, Gulabivala K (2002) An in vitro comparison of the bactericidal efficacy of lethal photosensitization or sodium hyphochlorite irrigation on Streptococcus intermedius biofilms in root canals. Int Endod J 35:268–274PubMedCrossRefGoogle Scholar
  72. 72.
    Segalla A, Borsarelli CD, Braslavsky SE, Spikes JD, Roncucci G, Dei D, Chiti G, Jori G, Reddi E (2002) Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine. Photochem Photobiol Sci 1:641–648PubMedCrossRefGoogle Scholar
  73. 73.
    Sharma S, Verma KK (2001) Skin and soft tissue infection. Indian J Pediatr 68(Suppl 3):S46–S50PubMedGoogle Scholar
  74. 74.
    Sievert D, Boulton M, Stoltman G, Johnson D, Stobierski M, Downes F, Somsel P, Rudrik J, Brown W, Hafeez W, Lundstrom T, Flanagan E, Johnson R, Mitchell J, Chang S, Center of Disease Control (2002) Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR Morb Mortal Wkly Rep 51:565–567Google Scholar
  75. 75.
    Slots J, Rams TE (1990) Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 17:479–493PubMedCrossRefGoogle Scholar
  76. 76.
    Socransky SS, Haffajee AD (1994) Implications of periodontal microbiology for the treatment of periodontal infections. Compend Suppl (18):S684–S685, 688–693; quiz S714–S717PubMedGoogle Scholar
  77. 77.
    Soukos NS, Mulholland SE, Socransky SS, Doukas AG (2003) Photodestruction of human dental plaque bacteria: enhancement of the photodynamic effect by photomechanical waves in an oral biofilm model. Lasers Surg Med 33:161–168PubMedCrossRefGoogle Scholar
  78. 78.
    Stern RS, Laird N (1994) The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Cancer 73:2759–2764PubMedCrossRefGoogle Scholar
  79. 79.
    Stern RS, Nichols KT, Vakeva LH (1997) Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med 336:1041–1045PubMedCrossRefGoogle Scholar
  80. 80.
    Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB (1979) Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 300:809–813PubMedCrossRefGoogle Scholar
  81. 81.
    Stringer MR, Collins P, Robinson DJ, Stables GI, Sheehan-Dare RA (1996) The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 107:76–81PubMedCrossRefGoogle Scholar
  82. 82.
    Tappeiner Hv (1904) Zur Kenntnis der lichtwirkenden (fluoreszierenden) Stoffe. Dtsch Med Wochenschr 1:579–580CrossRefGoogle Scholar
  83. 83.
    Tappeiner Hv, Jodlbauer A (1904) Über die Wirkung der photodynamischen (fluoreszierenden) Stoffe auf Infusorien. Dtsch Arch Klin Med 80:427–487Google Scholar
  84. 84.
    Tegos GP, Demidova TN, Arcila-Lopez D, Lee H, Wharton T, Gali H, Hamblin MR (2005) Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol 12:1127–1135PubMedCrossRefGoogle Scholar
  85. 85.
    Teichert MC, Jones JW, Usacheva MN, Biel MA (2002) Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:155–160PubMedCrossRefGoogle Scholar
  86. 86.
    van Gemert MJ, Jacques SL, Sterenborg HJ, Star WM (1989) Skin optics. IEEE Trans Biomed Eng 36:1146–1154PubMedCrossRefGoogle Scholar
  87. 87.
    Veien NK (1998) The clinician’s choice of antibiotics in the treatment of bacterial skin infection. Br J Dermatol 139(Suppl 53):30–36PubMedCrossRefGoogle Scholar
  88. 88.
    Wainwright M (1998) Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 42:13–28PubMedCrossRefGoogle Scholar
  89. 89.
    Wakayama Y, Takagi M, Yano K (1980) Photosensitized inactivation of E. coli cells in toluidine blue-light system. Photochem Photobiol 32:601–605PubMedGoogle Scholar
  90. 90.
    Walker CB (1996) The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 10:79–88PubMedCrossRefGoogle Scholar
  91. 91.
    Wilson M (2004) Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections. Photochem Photobiol Sci 3:412–418PubMedCrossRefGoogle Scholar
  92. 92.
    Wilson M, Dobson J, Sarkar S (1993) Sensitization of periodontopathogenic bacteria to killing by light from a low-power laser. Oral Microbiol Immunol 8:182–187PubMedGoogle Scholar
  93. 93.
    Wood S, Nattress B, Kirkham J, Shore R, Brookes S, Griffiths J, Robinson C (1999) An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. J Photochem Photobiol B 50:1–7PubMedCrossRefGoogle Scholar
  94. 94.
    Wyatt TD, Ferguson WP, Wilson TS, McCormick E (1977) Gentamicin resistant Staphylococcus aureus associated with the use of topical gentamicin. J Antimicrob Chemother 3:213–217PubMedCrossRefGoogle Scholar
  95. 95.
    Yamamoto T, Katayama I, Nishioka K (1998) Clinical analysis of staphylococcal superantigen hyper-reactive patients with psoriasis vulgaris. Eur J Dermatol 8:325–329PubMedGoogle Scholar
  96. 96.
    Zanin IC, Lobo MM, Rodrigues LK, Pimenta LA, Hofling JF, Goncalves RB (2006) Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur J Oral Sci 114:64–69PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2006

Authors and Affiliations

  1. 1.Department of DermatologyUniversity of RegensburgRegensburgGermany

Personalised recommendations